Skip to main content

Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades

Analysts at Goldman Sachs downgraded Team Health Holdings LLC (NYSE: TMH) from Buy to Neutral. The price target for Team Health Holdings is set to $68. Team Health Holdings' shares closed at $58.98 yesterday.

Analysts at Keefe Bruyette & Woods downgraded Citizens Financial Group Inc (NYSE: CFG) from Outperform to Market Perform. The price target for Citizens Financial Group is set to $28. Citizens Financial Group's shares closed at $27.75 yesterday.

Analysts at B.Riley downgraded 8x8, Inc. (NASDAQ: EGHT) from Buy to Neutral. 8x8 shares closed at $8.95 yesterday.

Analysts at Goldman Sachs downgraded Envision Healthcare Holdings Inc (NYSE: EVHC) from Conviction Buy to Buy. The price target for Envision Healthcare Holdings is set to $43. Envision Healthcare Holdings' shares closed at $37.25 yesterday.

Longbow Research downgraded Diodes Incorporated (NASDAQ: DIOD) from Buy to Neutral. Diodes' shares closed at $25.99 yesterday.

Baird downgraded Zumiez Inc. (NASDAQ: ZUMZ) from Outperform to Neutral. Zumiez shares closed at $29.74 yesterday.

Latest Ratings for TMH

Dec 2016JefferiesDowngradesBuyHold
Nov 2016Wells FargoDowngradesOutperformMarket Perform
Oct 2016Leerink SwannDowngradesOutperformMarket Perform

View More Analyst Ratings for TMH
View the Latest Analyst Ratings


Related Articles (TMH + CFG)

View Comments and Join the Discussion!

Posted-In: Top DowngradesDowngrades Analyst Ratings

Latest Ratings

GDWolfe ResearchDowngrades
QRTEAB of A SecuritiesInitiates Coverage On
ABB of A SecuritiesDowngrades42.0
VCTRB of A SecuritiesUpgrades32.0
BSIGB of A SecuritiesUpgrades27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at